[{"address1": "333 Lakeside Drive", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 574 3000", "fax": "650 578 9264", "website": "https://www.gilead.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.", "fullTimeEmployees": 17600, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel P.  O'Day", "age": 60, "title": "Chairman & CEO", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 7137565, "exercisedValue": 0, "unexercisedValue": 30103994}, {"maxAge": 1, "name": "Mr. Andrew D. Dickinson", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 2729705, "exercisedValue": 5536695, "unexercisedValue": 8763160}, {"maxAge": 1, "name": "Ms. Erin  Burkhart", "age": 46, "title": "SVP, Controller & Principal Accounting Officer", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jacquie  Ross C.F.A.", "title": "Senior Vice President of Treasury and Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Keeley  Wettan", "title": "Executive VP and General Counsel of Legal & Compliance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jyoti K. Mehra", "age": 49, "title": "Executive Vice President of Human Resources", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Linda Slanec Higgins Ph.D.", "age": 63, "title": "Senior Vice President of Research, Innovation & Portfolio", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Flavius  Martin M.D.", "title": "Executive Vice President of Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Janet  Dorling", "age": 51, "title": "Senior Vice President of Intercontinental Region & Global Patient Solutions", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard M. Fine M.D., Ph.D.", "title": "VP of Oncology & Franchise Head of Early Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 5, "compensationRisk": 4, "shareHolderRightsRisk": 2, "overallRisk": 3, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-irhome", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 139.55, "open": 139.02, "dayLow": 138.65, "dayHigh": 142.2, "regularMarketPreviousClose": 139.55, "regularMarketOpen": 139.02, "regularMarketDayLow": 138.65, "regularMarketDayHigh": 142.2, "dividendRate": 3.16, "dividendYield": 2.26, "exDividendDate": 1765756800, "payoutRatio": 0.48610002, "fiveYearAvgDividendYield": 3.79, "beta": 0.349, "trailingPE": 21.605783, "forwardPE": 16.238724, "volume": 9301829, "regularMarketVolume": 9301829, "averageVolume": 7201580, "averageVolume10days": 9056160, "averageDailyVolume10Day": 9056160, "bid": 141.83, "ask": 142.18, "bidSize": 1, "askSize": 1, "marketCap": 176132538368, "fiftyTwoWeekLow": 93.37, "fiftyTwoWeekHigh": 142.2, "allTimeHigh": 141.71, "allTimeLow": 0.207031, "priceToSalesTrailing12Months": 6.0553694, "fiftyDayAverage": 125.1168, "twoHundredDayAverage": 115.5455, "trailingAnnualDividendRate": 3.14, "trailingAnnualDividendYield": 0.022500897, "currency": "USD", "tradeable": false, "enterpriseValue": 192481476608, "profitMargins": 0.27882, "floatShares": 1238036975, "sharesOutstanding": 1240679623, "sharesShort": 22974646, "sharesShortPriorMonth": 21650110, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.0185, "heldPercentInsiders": 0.00095, "heldPercentInstitutions": 0.92186, "shortRatio": 3.62, "shortPercentOfFloat": 0.0185, "impliedSharesOutstanding": 1240806917, "bookValue": 17.343, "priceToBook": 8.184858, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "earningsQuarterlyGrowth": 1.436, "netIncomeToCommon": 8110000128, "trailingEps": 6.57, "forwardEps": 8.74145, "lastSplitFactor": "2:1", "lastSplitDate": 1359331200, "enterpriseToRevenue": 6.617, "enterpriseToEbitda": 13.616, "52WeekChange": 0.41847932, "SandP52WeekChange": 0.16255379, "lastDividendValue": 0.79, "lastDividendDate": 1765756800, "quoteType": "EQUITY", "currentPrice": 141.95, "targetHighPrice": 159.0, "targetLowPrice": 103.0, "targetMeanPrice": 139.46153, "targetMedianPrice": 142.5, "recommendationMean": 1.65517, "recommendationKey": "buy", "numberOfAnalystOpinions": 26, "totalCash": 8489999872, "totalCashPerShare": 6.843, "ebitda": 14136000512, "totalDebt": 24941000704, "quickRatio": 1.105, "currentRatio": 1.453, "totalRevenue": 29087000576, "debtToEquity": 116.243, "revenuePerShare": 23.354, "returnOnAssets": 0.12571, "returnOnEquity": 0.40706003, "grossProfits": 22896001024, "freeCashflow": 8028000256, "operatingCashflow": 9667000320, "earningsGrowth": 1.43, "revenueGrowth": 0.03, "grossMargins": 0.78716004, "ebitdaMargins": 0.48599, "operatingMargins": 0.45231, "financialCurrency": "USD", "symbol": "GILD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 1.7198093, "regularMarketPrice": 141.95, "shortName": "Gilead Sciences, Inc.", "longName": "Gilead Sciences, Inc.", "marketState": "CLOSED", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 7201580, "fiftyTwoWeekLowChange": 48.579994, "fiftyTwoWeekLowChangePercent": 0.5202955, "fiftyTwoWeekRange": "93.37 - 142.2", "fiftyTwoWeekHighChange": -0.25, "fiftyTwoWeekHighChangePercent": -0.0017580872, "fiftyTwoWeekChangePercent": 41.84793, "dividendDate": 1767052800, "earningsTimestamp": 1770757200, "earningsTimestampStart": 1770757200, "earningsTimestampEnd": 1770757200, "earningsCallTimestampStart": 1770759000, "earningsCallTimestampEnd": 1770759000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 6.57, "epsForward": 8.74145, "epsCurrentYear": 8.11368, "priceEpsCurrentYear": 17.495144, "fiftyDayAverageChange": 16.833199, "fiftyDayAverageChangePercent": 0.13453987, "twoHundredDayAverageChange": 26.404495, "twoHundredDayAverageChangePercent": 0.22852032, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 696090600000, "postMarketChangePercent": 0.70447344, "postMarketPrice": 142.95, "postMarketChange": 1.0, "regularMarketChange": 2.399994, "regularMarketDayRange": "138.65 - 142.2", "corporateActions": [], "postMarketTime": 1769820630, "regularMarketTime": 1769806801, "exchange": "NMS", "messageBoardId": "finmb_29002", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "Gilead Sciences", "trailingPegRatio": 0.2542, "__fetch_time": "2026-01-31"}]